<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35501478</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1433-9285</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>03</Day>
            </PubDate>
          </JournalIssue>
          <Title>Social psychiatry and psychiatric epidemiology</Title>
          <ISOAbbreviation>Soc Psychiatry Psychiatr Epidemiol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Unintentional drug-related deaths in people with mental illness in NSW Australia, 2012-2016: a retrospective cohort study.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00127-022-02280-4</ELocationID>
        <Abstract>
          <AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">People with mental illness are a vulnerable and stigmatised group with poor health outcomes including greater premature mortality. This study aimed to investigate trends and rates of change in unintentional drug-related deaths for people with mental illness, describe types of medicines involved, and identify populations at risk in a cohort from New South Wales, Australia.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">Features of unintentional drug-related deaths for people with mental illness between 2012 and 2016 were identified in a retrospective review of data from the National Coronial Information System.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 495 unintentional drug-related deaths were identified (1.6 deaths/100,000 population), showing an upward trend (p &lt; 0.01). The most common substance involved was diazepam in both genders (males 135/319, 42%, female 76/176, 43%) and more than one contributory drug was included in 80% of cases. Between 2012 and 2016, amphetamine-related deaths showed the highest increase (3.2-fold), followed by codeine (2.5-fold) and quetiapine (2.5-fold). Males (RR 1.8, 95% CI 1.5-2.2) and people aged 35-44 (RR 1.7, CI 1.3-2.2) were more likely to die from unintentional drug-related deaths compared with the reference (females and people aged 25-34).</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This study found that the drugs commonly involved in deaths are also the drugs commonly used by and prescribed to people with mental illness. There were also significant differences between gender, age group, and marital status in the trend and rate of unintentional drug-related deaths for people with mental illness. A multifaceted approach encompassing both pharmaceutical prescribing and targeted public health messaging is required to inform intervention and prevention strategies.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Smith-Merry</LastName>
            <ForeName>Jennifer</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-6705-2652</Identifier>
            <AffiliationInfo>
              <Affiliation>Centre for Disability Research and Policy, School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia. jennifer.smith-merry@sydney.edu.au.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fujita</LastName>
            <ForeName>Kenji</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0001-7876-6004</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chen</LastName>
            <ForeName>Tim</ForeName>
            <Initials>T</Initials>
            <Identifier Source="ORCID">0000-0003-4189-8403</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baillie</LastName>
            <ForeName>Andrew</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-3424-5703</Identifier>
            <AffiliationInfo>
              <Affiliation>School of Health Sciences and Matilda Centre for Research in Mental Health and Substance Abuse, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2006, Australia.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Soc Psychiatry Psychiatr Epidemiol</MedlineTA>
        <NlmUniqueID>8804358</NlmUniqueID>
        <ISSNLinking>0933-7954</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Adverse events</Keyword>
        <Keyword MajorTopicYN="N">Drug interactions</Keyword>
        <Keyword MajorTopicYN="N">Illicit drugs</Keyword>
        <Keyword MajorTopicYN="N">Mental illness</Keyword>
        <Keyword MajorTopicYN="N">Mortality</Keyword>
        <Keyword MajorTopicYN="N">Pharmaceutical drugs</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>22</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
          <Hour>23</Hour>
          <Minute>22</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>3</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35501478</ArticleId>
        <ArticleId IdType="doi">10.1007/s00127-022-02280-4</ArticleId>
        <ArticleId IdType="pii">10.1007/s00127-022-02280-4</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>International Overdose Awareness Day (2013) Overdose: worse than the road toll. http://www.overdoseday.com/wp-content/uploads/Factsheet-Greater-than-the-Road-Toll-KE-FINAL-15-August-2013.pdf .</Citation>
        </Reference>
        <Reference>
          <Citation>Penington Institute (2019) Australia’s annual overdose report 2019. Penington Institute https://www.penington.org.au/wp-content/uploads/Australias-Annual-Overdose-Report-2019.pdf .</Citation>
        </Reference>
        <Reference>
          <Citation>Davis MA, Lin LA, Liu H, Sites BD (2017) Prescription opioid use among adults with mental health disorders in the United States. J Am Board Fam Med 30(4):407–417. https://doi.org/10.3122/jabfm.2017.04.170112</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3122/jabfm.2017.04.170112</ArticleId>
            <ArticleId IdType="pubmed">28720623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goesling J, Henry MJ, Moser SE, Rastogi M, Hassett AL, Clauw DJ, Brummett CM (2015) Symptoms of depression are associated with opioid use regardless of pain severity and physical functioning among treatment-seeking patients with chronic pain. J Pain 16(9):844–851. https://doi.org/10.1016/j.jpain.2015.05.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jpain.2015.05.010</ArticleId>
            <ArticleId IdType="pubmed">26080041</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harris EC, Barraclough B (1998) Excess mortality of mental disorder. Br J Psychiatry: J Mental Sci 173:11</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1192/bjp.173.1.11</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Holt R, Peveler RC (2010) Diabetes and cardiovascular risk in severe mental illness: a missed opportunity and challenge for the future. Pract Diabetes Int 27(2):79–84ii. https://doi.org/10.1002/pdi.1451</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pdi.1451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tidemalm DW, Stefansson M, Elofsson C, Runeson S (2008) Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services. (Res Rep) Clin Pract Epidemiol Mental Health 4(23):23</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2020) Mental health services in Australia. AIHW, Canberra</Citation>
        </Reference>
        <Reference>
          <Citation>Whiteford H, Buckingham B, Harris M, Diminic S, Stockings E, Degenhardt L (2017) Estimating the number of adults with severe and persistent mental illness who have complex, multi-agency needs. Aust N Z J Psychiatry 51(8):799–809. https://doi.org/10.1177/0004867416683814</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0004867416683814</ArticleId>
            <ArticleId IdType="pubmed">28718716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2020) Physical health of people with mental illness. AIHW, Canberra</Citation>
        </Reference>
        <Reference>
          <Citation>Deady M, Teesson M, Mills K, Kay-Lambkin F, Baker A, Baillie A, Shand F, Manns L, Christensen H, Haber P (2013) One person, diverse needs: living with mental health and drug and alcohol difficulties. NHMRC Centre of Research Excellence in Mental Health and Substance Use: Sydney. https://www.mentalhealthcommission.gov.au/getmedia/8bff246f-4ffd-4eda-9716-db8c19d8d01b/One-person-diverseneeds-Living-with-a-mental-illness-as-well-as-the-challenges-from-difficulties-with-alcohol-and-drugs-use</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2020) National drug strategy household survey 2019. AIHW, Canberra. https://doi.org/10.25816/e42p-a447</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.25816/e42p-a447</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sullivan ME, Zhang M, Unützer L, Wells J (2006) Association between mental health disorders, problem drug use, and regular prescription opioid use. Arch Intern Med 166(19):2087–2093. https://doi.org/10.1001/archinte.166.19.2087</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.166.19.2087</ArticleId>
            <ArticleId IdType="pubmed">17060538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, Paulozzi LJ (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300(22):2613–2620. https://doi.org/10.1001/jama.2008.802</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.2008.802</ArticleId>
            <ArticleId IdType="pubmed">19066381</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2017) Mental health services—in brief 2017. AIHW, Canberra</Citation>
        </Reference>
        <Reference>
          <Citation>Hancock N, Smith-Merry J, Gillespie JA, Yen I (2017) Is the Partners in Recovery program connecting with the intended population of people living with severe and persistent mental illness? What are their prioritised needs? Aust Health Rev 41(5):566–572. https://doi.org/10.1071/AH15248</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1071/AH15248</ArticleId>
            <ArticleId IdType="pubmed">27584006</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morgan AJ, Wright J, Reavley NJ (2021) Review of Australian initiatives to reduce stigma towards people with complex mental illness: what exists and what works? Int J Ment Heal Syst 15(1):10–10. https://doi.org/10.1186/s13033-020-00423-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13033-020-00423-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doran CM, Kinchin I (2019) A review of the economic impact of mental illness. Aust Health Rev 43(1):43–48. https://doi.org/10.1071/AH16115</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1071/AH16115</ArticleId>
            <ArticleId IdType="pubmed">29129189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ye J, Chen TF, Paul D, McCahon R, Shankar S, Rosen A, O’Reilly CL (2016) Stigma and discrimination experienced by people living with severe and persistent mental illness in assertive community treatment settings. Int J Soc Psychiatry 62(6):532–541. https://doi.org/10.1177/0020764016651459</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0020764016651459</ArticleId>
            <ArticleId IdType="pubmed">27335339</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Bureau of Statistics (2021) National, state and territory population. Australian Bureau of Statistics. https://www.abs.gov.au/statistics/people/population/national-state-and-territory-population/latest-release . Accessed 2021 2022</Citation>
        </Reference>
        <Reference>
          <Citation>National Coronial Information System (2019) NCIS case closure figures—July 2019. . national coronial information system. https://www.ncis.org.au/wp-content/uploads/2019/07/case-closure-statistics.pdf . Accessed 22/08/2021 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Bureau of Statistics (2016) 3303.0—causes of death, Australia. Australian Bureau of Statistics, Canberra</Citation>
        </Reference>
        <Reference>
          <Citation>New South Wales Government (2007) NSW mental health act (2007), chapter 1, section 4. https://www.legislation.nsw.gov.au/#/view/act/2007/8/chap1/sec4 .</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Bureau of Statistics (2020) Australian demographic statistics: estimated resident population by single year of age, New South Wales. Australian Bureau of Statistics. https://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3101.0Dec%202019?OpenDocument .</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Bureau of Statistics (2016) Census 2016, registered marital status by age by sex (LGA) Australian Bureau of Statistics. http://stat.data.abs.gov.au/Index.aspx?DataSetCode=ABS_C16_T02_LGA .</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2015) Australia’s welfare 2015: Mental health of older Australians. https://www.aihw.gov.au/getmedia/c2ff6c58-e05e-49ed-afd7-43bd21eef4e2/AW15-6-4-Mental-health-of-older-Australians.pdf.aspx .</Citation>
        </Reference>
        <Reference>
          <Citation>Australian Bureau of Statistics and Australian Institute of Health and Welfare (2003) Drug Induced Deaths, Australia, 1991–2001 AIHW. https://www.abs.gov.au/ausstats/abs@.nsf/mf/3321.0.55.001 .</Citation>
        </Reference>
        <Reference>
          <Citation>Akaike H (1974) A new look at the statistical model identification. IEEE Trans Autom Control 19(6):716–723. https://doi.org/10.1109/TAC.1974.1100705</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1109/TAC.1974.1100705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Commission on Safety and Quality in Health Care (2017) Medication Safety in Mental Health.</Citation>
        </Reference>
        <Reference>
          <Citation>Goodwin RD, Amador XF, Malaspina D, Yale SA, Goetz RR, Gorman JM (2003) Anxiety and substance use comorbidity among inpatients with schizophrenia. Schizophr Res 61(1):89–95</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0920-9964(02)00292-X</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Australian Institute of Health and Welfare (2017) Non-medical use of pharmaceuticals: trends, harms and treatment 2006–07 to 2015–16. AIHW, Canberra</Citation>
        </Reference>
        <Reference>
          <Citation>Kaufmann CN, Spira AP, Alexander GC, Rutkow L, Mojtabai R (2017) Emergency department visits involving benzodiazepines and non-benzodiazepine receptor agonists. Am J Emerg Med 35(10):1414–1419</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajem.2017.04.023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Monheit B, Pietrzak D, Hocking S (2016) Prescription drug abuse—A timely update. Am Family Phys 45(12):862–866</Citation>
        </Reference>
        <Reference>
          <Citation>Brett J, Murnion B (2015) Management of benzodiazepine misuse and dependence. Aust Prescr 38(5):152–155. https://doi.org/10.18773/austprescr.2015.055</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18773/austprescr.2015.055</ArticleId>
            <ArticleId IdType="pubmed">26648651</ArticleId>
            <ArticleId IdType="pmc">4657308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schaffer AL, Buckley NA, Cairns R, Pearson S (2019) Comparison of prescribing patterns before and after implementation of a national policy to reduce inappropriate alprazolam prescribing in Australia. JAMA Netw Open 2(9):e1911590–e1911590. https://doi.org/10.1001/jamanetworkopen.2019.11590</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.11590</ArticleId>
            <ArticleId IdType="pubmed">31532519</ArticleId>
            <ArticleId IdType="pmc">6751760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Therapeutic Goods Administration (2021) Prescription opioids: what changes are being made and why. Therapeutic Goods Administration. https://www.tga.gov.au/prescription-opioids-what-changes-are-being-made-and-why . Accessed 2021 2022</Citation>
        </Reference>
        <Reference>
          <Citation>Brett J, Pearson SA, Daniels B, Wylie CE, Buckley NA (2021) A cross sectional study of psychotropic medicine use in Australia in 2018: a focus on polypharmacy. Br J Clin Pharmacol 87(3):1369–1377. https://doi.org/10.1111/bcp.14527</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bcp.14527</ArticleId>
            <ArticleId IdType="pubmed">32881057</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>John AP, Gee T, Alexander S, Ramankutty P, Dragovic M (2014) Prevalence and nature of antipsychotic polypharmacy among inpatients with schizophrenia spectrum disorders at an Australian mental health service. Australas Psychiatry: Bull Royal Aust New Zealand Coll Psychiatr 22(6):546–550. https://doi.org/10.1177/1039856214546672</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1039856214546672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Calati R, Ferrari C, Brittner M, Oasi O, Olié E, Carvalho AF, Courtet P (2019) Suicidal thoughts and behaviors and social Isolation: a narrative review of the literature. J Affect Disord 15(245):653–667</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jad.2018.11.022</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Richards M, Hardy R, Wadsworth M (1997) The effects of divorce and separation on mental health in a national UK birth cohort. Psychol Med 27(5):1121–1128. https://doi.org/10.1017/S003329179700559X</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S003329179700559X</ArticleId>
            <ArticleId IdType="pubmed">9300516</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bagshaw D, Brown T, Wendt S, Campbell A, McInnes E, Tinning B, Batagol B, Sifris A, Tyson D, Baker J, Arias PF (2011) The effect of family violence on post-separation parenting arrangements: the experiences and views of children and adults from families who separated post-1995 and post-2006. Fam Matters 86:49–61</Citation>
        </Reference>
        <Reference>
          <Citation>Fortuna KL, Ferron J, Pratt SI, Muralidharan A, Aschbrenner KA, Williams AM, Deegan PE, Salzer M (2019) Unmet needs of people with serious mental illness: perspectives from certified peer specialists. Psychiatr Q 90(3):579–586. https://doi.org/10.1007/s11126-019-09647-y</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11126-019-09647-y</ArticleId>
            <ArticleId IdType="pubmed">31154551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andrews, G., Hall, W., Teesson, M., &amp; Henderson, S. (1999). The mental health of Australians. Canberra: Mental Health Branch, Commonwealth Department of Health and Aged Care, pp 1–43</Citation>
        </Reference>
        <Reference>
          <Citation>Murray ACL (1996) The global burden of disease : a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Harvard School of Public Health, World Health Organization and the World Bank, Cambridge, MA</Citation>
        </Reference>
        <Reference>
          <Citation>Health. NSWDo (2000) The management of people with a co-existing mental health and substance use disorder/NSW Health. State health publication; no. (CMH) 000040; 000050., vol Accessed from https://nla.gov.au/nla.cat-vn558467 . NSW Health Dept, Gladesville, N.S.W</Citation>
        </Reference>
        <Reference>
          <Citation>Nielsen BK, Raphael EB (2014) Males and mental health: a public health approach. Centre for Mental Health, NSW Department of Health</Citation>
        </Reference>
        <Reference>
          <Citation>De Leo D, Dudley MJ, Aebersold CJ, Mendoza JA, Barnes MA, Harrison JE, Ranson DL (2010) Achieving standardised reporting of suicide in Australia: rationale and program for change. Med J Aust 192:452–456</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.5694/j.1326-5377.2010.tb03584.x</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
